AT269350B - Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen - Google Patents

Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen

Info

Publication number
AT269350B
AT269350B AT1097465A AT1097465A AT269350B AT 269350 B AT269350 B AT 269350B AT 1097465 A AT1097465 A AT 1097465A AT 1097465 A AT1097465 A AT 1097465A AT 269350 B AT269350 B AT 269350B
Authority
AT
Austria
Prior art keywords
new
production
antibiotic substances
antibiotic
substances
Prior art date
Application number
AT1097465A
Other languages
English (en)
Original Assignee
Danbal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbal Ag filed Critical Danbal Ag
Application granted granted Critical
Publication of AT269350B publication Critical patent/AT269350B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1097465A 1964-12-07 1965-12-06 Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen AT269350B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US416599A US3361742A (en) 1964-12-07 1964-12-07 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides

Publications (1)

Publication Number Publication Date
AT269350B true AT269350B (de) 1969-03-10

Family

ID=23650586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1097465A AT269350B (de) 1964-12-07 1965-12-06 Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen

Country Status (11)

Country Link
US (1) US3361742A (de)
AT (1) AT269350B (de)
BE (1) BE673376A (de)
BR (1) BR6575537D0 (de)
CH (1) CH475997A (de)
DE (1) DE1467872A1 (de)
ES (1) ES320436A1 (de)
FR (1) FR1553664A (de)
GB (1) GB1092888A (de)
NL (1) NL6515880A (de)
SE (1) SE316136B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523941A (en) * 1967-03-06 1970-08-11 Hoffmann La Roche Benzodiazepine compounds and process for their preparation
US3524849A (en) * 1967-10-27 1970-08-18 Hoffmann La Roche Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein
FR2027356A1 (en) * 1968-12-30 1970-09-25 Fujisawa Pharmaceutical Co Benzodiazepinone antibiotics
JPS5279082A (en) * 1975-12-25 1977-07-02 Green Cross Corp:The Preparation of anti-tumor compound
JPS585916B2 (ja) 1977-12-27 1983-02-02 株式会社ミドリ十字 新規ベンゾジアゼピン系化合物
CA1214774A (en) * 1983-02-10 1986-12-02 Yusei Shiraga Benzodiazepine derivative
AUPO470197A0 (en) * 1997-01-21 1997-02-13 Attfield, Paul Victor Fluorescent dyes from microorganisms
JP5870400B2 (ja) 2010-04-15 2016-03-01 シアトル ジェネティクス,インコーポレーテッド 標的化ピロロベンゾジアゼピンコンジュゲート
ES2623057T3 (es) 2010-04-15 2017-07-10 Medimmune Limited Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas
SG11201400770SA (en) 2011-09-20 2014-04-28 Spirogen Sarl Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
US9526798B2 (en) 2011-10-14 2016-12-27 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
SG11201401021TA (en) 2011-10-14 2014-08-28 Spirogen Sarl Pyrrolobenzodiazepines
CN103998449A (zh) 2011-10-14 2014-08-20 斯皮罗根有限公司 吡咯并苯并二氮杂卓
MX358757B (es) 2011-10-14 2018-09-03 Seattle Genetics Inc Pirrolobenzodiazepinas y conjugados dirigidos.
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
ES2649990T3 (es) 2012-10-12 2018-01-16 Medimmune Limited Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas
US9745303B2 (en) 2012-10-12 2017-08-29 Medimmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
EP2906296B1 (de) 2012-10-12 2018-03-21 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
WO2014057114A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-psma antibody conjugates
BR112015008251B1 (pt) 2012-10-12 2023-09-26 Medimmune Limited Pirrolobenzodiazepinas, conjugados destas, composição e composição farmacêutica compreendendo os conjugados, uso dos conjugados para o tratamento de uma doença proliferativa e método para preparar os conjugados
NZ707486A (en) 2012-10-12 2018-09-28 Adc Therapeutics Sa Pyrrolobenzodiazepine - anti-psma antibody conjugates
US9931414B2 (en) 2012-10-12 2018-04-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
ES2738310T3 (es) 2012-10-12 2020-01-21 Medimmune Ltd Pirrolobenzodiazepinas y conjugados de las mismas
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054985B1 (de) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
EP3054986B1 (de) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
EP3054983B1 (de) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
EP3223854A1 (de) 2014-11-25 2017-10-04 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
US11160872B2 (en) 2017-02-08 2021-11-02 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
EP3612537B1 (de) 2017-04-18 2022-07-13 Medimmune Limited Pyrrolobenzodiazepinkonjugate
CN110536703B (zh) 2017-04-20 2024-07-12 Adc治疗有限公司 使用抗axl抗体-药物缀合物的组合疗法
UA127900C2 (uk) 2017-06-14 2024-02-07 Ейдісі Терапьютікс Са Схема дозування для введення adc до cd19
RS62928B1 (sr) 2017-08-18 2022-03-31 Medimmune Ltd Konjugati pirolobenzodiazepina
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
ES2967878T3 (es) 2019-03-15 2024-05-06 Medimmune Ltd Dímeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento del cáncer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247187A (en) * 1963-07-10 1966-04-19 Hoffmann La Roche Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones

Also Published As

Publication number Publication date
ES320436A1 (es) 1966-05-16
FR1553664A (de) 1969-01-17
CH475997A (de) 1969-07-31
NL6515880A (de) 1966-06-08
BE673376A (de) 1966-04-01
US3361742A (en) 1968-01-02
GB1092888A (en) 1967-11-29
BR6575537D0 (pt) 1973-09-06
SE316136B (de) 1969-10-20
DE1467872A1 (de) 1969-05-14

Similar Documents

Publication Publication Date Title
CH478156A (de) Verfahren zur Herstellung neuartiger Antibiotika
CH456636A (de) Verfahren zur Herstellung von neuen Aminen
CH475241A (de) Verfahren zur Herstellung von neuen Pyrrolderivaten
AT264136B (de) Verfahren zur Herstellung von neuen Copolyestern
CH473117A (de) Verfahren zur Herstellung von neuen Verbindungen
CH468977A (de) Verfahren zur Herstellung von neuen Carbamaten
CH471129A (de) Verfahren zur Herstellung von neuen Noralkaloiden
CH488640A (de) Verfahren zur Herstellung von neuen Cycloheptadienen
AT250981B (de) Verfahren zur Herstellung von neuen alkalilöslichen Kondensationsprodukten
AT265515B (de) Verfahren zur Herstellung von neuen Penicillinen
AT266314B (de) Verfahren zur Herstellung des neuen Antibiotikums Lincomycin B
AT256858B (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT261804B (de) Verfahren zur Herstellung von neuen wasserlöslichen, antibiotisch wirksamen Verbindungen
AT264711B (de) Verfahren zur Herstellung von neuen Penicillinen
AT264003B (de) Verfahren zur Herstellung von neuen Penicillinen
AT284089B (de) Verfahren zur herstellung von neuen substituierten beta-phenylaethanolen
CH457433A (de) Verfahren zur Herstellung von neuen basisch substituierten Pseudoindolen
AT282079B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
AT255435B (de) Verfahren zur Herstellung von neuen organischen Zinn-Bor-Verbindungen
CH434265A (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT268552B (de) Verfahren zur Herstellung von neuen α-Alkyl-thyroninen
AT257627B (de) Verfahren zur Herstellung von neuen S-Amino-iso-thio-harnstoffen
CH486421A (de) Verfahren zur Herstellung von neuen Phenoxyaminopropanen
AT270867B (de) Verfahren zur Herstellung von neuen Penicillinen
AT261807B (de) Verfahren zur Herstellung von neuen Penicillinen